Investors Heavily Search e.l.f. Beauty (ELF): Here is What You Need to Know
Recently, Zacks.com users have been paying close attention to e.l.f. Beauty (ELF).
Recently, Zacks.com users have been paying close attention to e.l.f. Beauty (ELF).
E.l.f. turned in strong revenue growth, led by its skincare brands Rhode and Naturium. Its namesake brand is seeing headwinds, but the company is testing lower price points to try to increase volumes.
Americans will pay more for everything from gas to meat for the barbecue heading into Memorial Day weekend. Prices for travel, recreation and food saw sharp increases, giving consumers headaches as the summer unofficially kicks off.
Down nearly 65% from the late 2025 highs, this market is trading at deep-value levels, with catalysts in play. While the guidance for fiscal 2027 was tepid, it reflects intentional price markdowns, aimed at driving volume.
e.l.f. Beauty posts fiscal fourth quarter sales growth of 35.1% as Rhode boosts results, while margins face pressure from higher operating costs.
elf Beauty Inc (NYSE:ELF) on Wednesday reported better-than-expected fourth-quarter financial results.
During e.l.f. Beauty's fiscal 2026 earnings call, its chairman and CEO Tarang Amin highlighted several strong performance indicators, but one remarkable figure stood out: the group has averaged 20% of net sales growth per quarter for the past seven years.
e.l.f. Beauty is reiterated as a buy after a strong fiscal Q4, with shares rebounding 9% post-earnings. ELF delivered 35% YoY revenue growth and a gross margin of 73%, beating consensus and issuing robust FY 2027 guidance. Valuation is compelling: ELF trades at a mid-teens P/E, with a $74 price target based on 22x $3.35 EPS, about $20 upside.
e.l.f. Beauty Inc (NYSE:ELF) reported fiscal fourth quarter results that topped Wall Street expectations on revenue and profitability, but issued fiscal 2027 guidance that came in below analyst estimates.
NVDA outperforms but China problems persist, Bloom and Nebius announce energy deal, and more
e.l.f. Beauty (ELF) delivered a mixed Q4, with a double beat but only 1% organic growth and rising SG&A expenses. Gross margin reached an impressive 73%, reflecting strong pricing power, but marketing and SG&A costs surged to 66% of sales. Despite current headwinds, ELF expects FY 2027 adjusted EBITDA margin to remain stable at ~20.7%, with mid single-digit organic growth.
e.l.f. Beauty Inc (NYSE:ELF) reported fiscal fourth quarter results that topped Wall Street expectations on revenue and profitability, but issued fiscal...
Shares of elf Beauty Inc (NYSE: ELF) rose sharply in pre-market trading after beating analyst expectations with fourth-quarter earnings of 32 cents per share and revenue of $449.29 million, up 35%. Other pre-market gainers include WHLR, ATPC, LIMN, JUNS, ILLR, NCPL, VIDA, WNW, and APLD. The biggest losers are WGRX, MMA, IPW, and CAPS.
e.l.f. Beauty, Inc. (ELF) Q4 2026 Earnings Call Transcript
e.l.f. Beauty plans to slash prices on some products in response to more price-sensitive consumers. A price-cut test on its Halo Glow skin tint led to a nearly 40% increase in sales.
NVIDIA's earnings grew +140% year over year, +85% on revenues. An $80B share repurchase was also announced.
e.l.f. Beauty (ELF) came out with quarterly earnings of $0.32 per share, beating the Zacks Consensus Estimate of $0.29 per share. This compares to earnings of $0.78 per share a year ago.
e.l.f. Beauty NYSE: ELF reported what executives described as a seventh consecutive year of “industry-leading” results, with fiscal 2026 net sales up 25% and adjusted EBITDA up 13%, while also signaling a more cautious near-term outlook for its core e.l.f. brand.
e.l.f Beauty Inc. (NYSE:ELF) posted its fourth-quarter results after Wednesday's closing bell, beating analyst estimates on the top and bottom lines. Here's a look inside the report.
Elf Beauty on Wednesday forecast annual sales and profit below analysts' expectations, and said surging oil prices tied to the Iran war could have a $15 million to $20 million impact in fiscal 2027.